Managing Side Effects

Using tests to identify minimal residual disease may help determine how much treatment patients with multiple myeloma require.

In addition to a breakthrough therapy designation for a lung cancer drug, this week we’ll be talking a lot about additional side effects and health conditions that may come with a cancer diagnosis, and how to manage them.

Tecvayli responses were found to be slightly lower in patients with relapsed/refractory myeloma treated with another BCMA-targeted therapy.

Last week, we saw a few moving parts in the regulatory space, from new NCCN guidelines for pediatric neuroblastoma treatment to FDA Fast Tracks and Priority Reviews

As up to 42% of patients with cancer may be using cannabis, one expert spoke to CURE® to separate cannabis myths from reality.

I need to acknowledge and address the impact stress from multiple myeloma has on my mental and emotional wellbeing.